Relationship between platelet-derived growth factor expression in leiomyomas and uterine volume changes after gonadotropin-releasing hormone agonist treatment

This publication has 20 references indexed in Scilit:

• Gonadotropin-releasing hormone analogue conjugates with strong selective antitumor activity
  Proceedings of the National Academy of Sciences, 1999
• Multiple Uterine Leiomyomas: Cytogenetic Analysis
  Gynecologic Oncology, 1999
• Karyotype Evolution in a Case of Uterine Angioleiomyoma
  Cancer Genetics and Cytogenetics, 1999
• Cellular proliferation, estrogen receptor, progesterone receptor, and bcl-2 expression in GnRH agonist-treated uterine leiomyomas
  Human Pathology, 1998
• Morphological Changes in Uterine Leiomyomas Treated by GnRH Agonist Goserelin
  International Journal of Gynecological Pathology, 1995
• Progesterone: A critical role in the pathogenesis of uterine myomas
  American Journal of Obstetrics and Gynecology, 1995
• Quantification of messenger ribonucleic acid for epidermal growth factor in human myometrium and leiomyomata using reverse transcriptase polymerase chain reaction
  Journal of Clinical Endocrinology & Metabolism, 1994
• Progesterone receptor messenger ribonucleic acid and protein are overexpressed in human uterine leiomyomas
  American Journal of Obstetrics and Gynecology, 1993
• Presence of messenger ribonucleic acid for epidermal growth factor (EGF) and EGF receptor demonstrable in monolayer cell cultures of myometria and leiomyomata
  Fertility and Sterility, 1991
• A conservative approach to the management of uterine leiomyoma: Pituitary desensitization by a luteinizing hormone-releasing hormone analogue
  American Journal of Obstetrics and Gynecology, 1983